Growth factor receptor antibodies
US5942602A · kind A · utility
40Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 1997 |
| Grant date | Aug 24, 1999 |
| Priority date | — |
| Expiry date | Feb 13, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to single and double chain antibodies to EGF receptor. The invention also relates to toxin conjugates of such antibodies. These antibodies are useful for treating and diagnosing the status of pathological conditions such as cancer and cellular hyper proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.